Computed tomography screening for lung cancer: where are we now?
Publication
, Journal Article
Christensen, JD; Tong, BC
Published in: North Carolina medical journal
September 2013
Low-dose computed tomography (LDCT) screening has been shown to result in detection of earlier-stage lung cancers, with a 20% reduction in cancer-related deaths. LDCT screening offers significant potential benefits to selected patients; however, many questions remain, including questions about the applicability of lung cancer screening in clinical practice.
Duke Scholars
Published In
North Carolina medical journal
ISSN
0029-2559
Publication Date
September 2013
Volume
74
Issue
5
Start / End Page
406 / 410
Related Subject Headings
- Tomography, X-Ray Computed
- Radiation Dosage
- Practice Guidelines as Topic
- Lung Neoplasms
- Humans
- False Positive Reactions
- Early Detection of Cancer
- Cost-Benefit Analysis
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Christensen, J. D., & Tong, B. C. (2013). Computed tomography screening for lung cancer: where are we now? North Carolina Medical Journal, 74(5), 406–410.
Christensen, Jared D., and Betty C. Tong. “Computed tomography screening for lung cancer: where are we now?” North Carolina Medical Journal 74, no. 5 (September 2013): 406–10.
Christensen JD, Tong BC. Computed tomography screening for lung cancer: where are we now? North Carolina medical journal. 2013 Sep;74(5):406–10.
Christensen, Jared D., and Betty C. Tong. “Computed tomography screening for lung cancer: where are we now?” North Carolina Medical Journal, vol. 74, no. 5, Sept. 2013, pp. 406–10.
Christensen JD, Tong BC. Computed tomography screening for lung cancer: where are we now? North Carolina medical journal. 2013 Sep;74(5):406–410.
Published In
North Carolina medical journal
ISSN
0029-2559
Publication Date
September 2013
Volume
74
Issue
5
Start / End Page
406 / 410
Related Subject Headings
- Tomography, X-Ray Computed
- Radiation Dosage
- Practice Guidelines as Topic
- Lung Neoplasms
- Humans
- False Positive Reactions
- Early Detection of Cancer
- Cost-Benefit Analysis
- 42 Health sciences
- 32 Biomedical and clinical sciences